Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Roche scores another FDA approval for Xofluza

Roche scores another FDA approval for Xofluza Roche holds worldwide rights to the drug, excluding Japan and Taiwan, which are retained exclusively by Shionogi.

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal UCB and Amgen now say they are hoping for an EMA approval before the end of the year, which will come after approvals for Evenity in the US and Japan earlier

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

Gilead promotes Andrew Dickinson to CFO, increased M&A expected

Gilead promotes Andrew Dickinson to CFO, increased M&A expected The drug is already under review in Europe and Japan, with plans to file in the US soon.

Gilead poaches Genentech-exec Merdad Parsey for its new CMO

Gilead poaches Genentech-exec Merdad Parsey for its new CMO Company also files potential blockbuster filgotinib in Japan. As new CEO Daniel O’Day continues to overhaul Gilead’s top positions, Roche subsidiary Genentech’s Merdad Parsey has been appointed as ... The Galapagos-partnered drug is due to be

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics